SCHEMBL5030908

SCHEMBL5030908

CS(=O)(=O)c1ccccc1-c1[c]cccc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.40
BAZ2B Q9UIF8 3/20 0.38
BAZ2A Q9UIF9 3/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
BRD9 Q9H8M2 1/20 0.38
KMT2A Q03164 3/20 0.37
ALOX5AP P20292 3/20 0.35
FEN1 P39748 3/20 0.35
PTGS2 P35354 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 1/20 0.34
MEN1 O00255 2/20 0.33
LMNA P02545 1/20 0.33
BCAT2 O15382 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8510774 0.81 TTR (0.38) ALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL7179095 0.81 FEN1 (0.41) ALDH1A1ALOX5APFEN1POLBLMNA
SCHEMBL3435329 0.79 HTR6 (0.46) ALDH1A1KDM4EKMT2AALOX5APFEN1
SCHEMBL7178906 0.78 NSD2 (0.45) RAB9AKDM4EKMT2AALOX5APFEN1
SCHEMBL8510448 0.77 NPC1 (0.30) RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL7186900 0.77 ALOX5AP (0.45) ALDH1A1KDM4EALOX5APFEN1SMN1; SMN2
SCHEMBL2761711 0.75 MEN1 (0.32) RAB9AALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL9211305 0.74 BAZ2B (0.38) HSD11B1BAZ2BBAZ2ARAB9AALDH1A1
SCHEMBL1970261 0.74 HSD11B1 (0.40) HSD11B1BAZ2BBAZ2ARAB9AALDH1A1
SCHEMBL7186577 0.74 L3MBTL1 (0.49) ALDH1A1KMT2AALOX5APFEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940406-A2 POTASSIUM CHANNEL INHIBITORS Merck and Co., Inc. (US) 2008-07-09 EP disclosed
WO-2007050348-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-05-03 WO disclosed
EP-1636175-A1 NOVEL COMPOUNDS AstraZeneca AB (SE) 2006-03-22 EP disclosed
WO-2004089884-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2004-10-21 WO disclosed